Centrally inserted external catheters and totally implantable ports for the delivery of chemotherapy: A systematic review and meta-analysis of device-related complications

CardioVascular and Interventional Radiology

Volumn 37, Issue 4, 2014, Pages 990-1008

  Kulkarni, S ^a   Wu, O ^b   Kasthuri, R ^a   Moss, Jon G ^a  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Central venous catheters; Complication rate; Infection rate; Meta analysis; Systematic review; Totally implantable port

Indexed keywords

HEPARIN; UROKINASE; ANTINEOPLASTIC AGENT;

ARTICLE; BACTEREMIA; BLEEDING; CANCER CHEMOTHERAPY; CATHETER COMPLICATION; CATHETER INFECTION; CATHETER REMOVAL; CENTRAL VENOUS CATHETER; HUMAN; IMPLANTABLE PORT SYSTEM; INFECTION RISK; META ANALYSIS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SYSTEMATIC REVIEW; ADVERSE EFFECTS; CENTRAL VENOUS CATHETERIZATION; DEVICE REMOVAL; DEVICES; INDWELLING CATHETER; NEOPLASMS;

ANTINEOPLASTIC AGENTS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; DEVICE REMOVAL; HUMANS; NEOPLASMS;

EID: 84904570552     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-013-0771-3     Document Type: Article

References (36)

1. http://www.hscic.gov.uk/searchcatalogue. Accessed 24 Mar 2013
2. Peters JL (2009) The history of central venous access. In: Hamilton H, Bodenham AR (eds) Central venous catheters. Wiley, Oxford
3. Boersma RS, Jie KSG, Verbon A, Van Pampus ECM, Schouten HC (2008) Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies. Ann Oncol 19(3):433-442 (Pubitemid 351325662)
4. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analysis: the PRISMA statement. PLos Med 6(7):e1000097
5. Scottish Intercollegiate Guidelines Network (2013) Search filters. http://www.sign.ac.uk/methodology/filters.html. Accessed 24 Mar 2013
6. Kmet LM, Lee RC, Cook LS (2004) Standard quality assessment criteria for evaluating primary research papers from a variety of fields. Alberta: Alberta Heritage Foundation for Medical Research, 2004 HTA Initiative no. 13
7. Dillon PW, Jones GR, Bagnall-Reeb HA, Buckley JD, Wiener ES, Haase GM (2004) Prophylactic urokinase in the management of long-term venous access devices in children: a children's oncology group study. J Clin Oncol 22(13):2718-2723 (Pubitemid 41103760)
8. Johansson E, Bjorkholm M, Bjorvell H, Hast R, Takolander R, Olofsson P et al (2004) Totally implantable subcutaneous port system versus central venous catheter placed before induction chemotherapy in patients with acute leukaemia: a randomized study. Support Care Cancer 12(2):99-105 (Pubitemid 38222495)
9. Carde P, Cossetdelaigue MF, Laplanche A, Chareau I (1989) Classical external indwelling central venous catheter versus totally implanted venous access systems for chemotherapy administration: a randomized trial in 100 patients with solid tumors. Eur J Cancer Clin Oncol 25(6):939-944 (Pubitemid 19148697)
10. Kappers-Klunne MC, Degener JE, Stijnen T, Abels J (1989) Complications from long-term indwelling central venous catheters in hematologic patients with special reference to infection. Cancer 64:1747-1752 (Pubitemid 19251150)
11. Mueller BU, Skelton J, Callender DPE, Marshall D, Gress J, Longo D et al (1992) A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer-patients. J Clin Oncol 10(12):1943
12. Adler A, Yaniv I, Steinberg R, Solter E, Samra Z, Stein J et al (2006) Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients. J Hospital Infect 62(3):358-365 (Pubitemid 43192330)
13. Allen RC, Holdsworth MT, Johnson CA, Chavez CM, Heideman RL, Overturf G et al (2008) Risk determinants for catheter-associated blood stream infections in children and young adults with cancer. Pediatr Blood Cancer 51(1):53-58 (Pubitemid 351720869)
14. Groeger JS, Lucas AB, Thaler HT, Friedlander-Klar H, Brown AE, Kiehn TE et al (1993) Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 119(12):1168-1174 (Pubitemid 23361446)
15. Ingram J, Weitzman S, Greenberg ML, Parkin P, Filler R (1991) Complications of indwelling venous access lines in the pediatric hematology patient: a prospective comparison of external venous catheters and subcutaneous ports. Am J Pediatr Hematol Oncol 13(2):130-136
16. La Quaglia MP, Caldwell C, Lucas A, Corbally M, Heller G, Steinherz L et al (1994) A prospective randomized double-blind trial of bolus urokinase in the treatment of established Hickman catheter sepsis in children. J Pediatr Surg 29(6):742-745 (Pubitemid 24191353)
17. Mirro J Jr, Rao BN, Stokes DC, Austin BA, Kumar M, Dahl GV et al (1989) A prospective study of Hickman/Broviac catheters and implantable ports in pediatric oncology patients. J Clin Oncol 7(2):214-222
18. Ross MN, Haase GM, Poole MA, Burrington JD, Odom LF (1998) Comparison of totally implanted reservoirs with external catheters as venous access devices in pediatric oncologic patients. Surg Gynecol Obstet 167(2):141-144
19. Wiener ES, McGuire P, Stolar CJ, Rich RH, Albo VC, Ablin AR et al (1992) The CCSG prospective study of venous access devices: An analysis of insertions and causes for removal. J Pediatr Surg 27(2):155-163 (discussion 163-164)
20. Wurzel CL, Halom K, Feldman JG, Rubin LG (1988) Infection rates of Broviac-Hickman catheters and implantable venous devices. Am J Dis Child 142(5):536-540
21. Handrup MM, Moller JK, Frydenberg M, Schroder H (2010) Placing of tunneled central venous catheters prior to induction chemotherapy in children with acute lymphoblastic leukemia. Pediatr Blood Cancer 55(2):309-313
22. Basford TJ, Poenaru D, Silva M (2003) Comparison of delayed complications of central venous catheters placed surgically or radiologically in pediatric oncology patients. J Pediatr Surg 38(5):788-792 (Pubitemid 36534816)
23. Beckers MM, Ruven HJT, Seldenrijk CA, Prins MH, Biesma DH (2010) Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated with cancer. Thrombosis Res 125:318-321
24. Eastridge BJ, Lefor AT (1995) Complications of Indwelling venous access devices in cancer-patients. J Clin Oncol 13(1):233-238
25. Estes JM, Rocconi R, Straughn JM, Bhoola S, Leath CA, Alvarez RD et al (2003) Complications of indwelling venous access devices in patients with gynecologic malignancies. Gynecol Oncol 91(3):591-595 (Pubitemid 38388156)
26. Gleeson NC, Fiorica JV, Mark JE, IPinelli DM, Hoffman MS, Roberts WS et al (1993) Externalized Groshong catheters and Hickman ports for central venous access in gynecologic oncology patients. Gynecol Oncol 51:372-376 (Pubitemid 24058614)
27. Guenier C, Ferreira J, Pector JC (1989) Prolonged venous access in cancer-patients. Eur J Surg Oncol 15(6):553-555
28. Keung YK, Watkins K, Chen SC, Groshen S, Silberman H, Douer D (1994) Comparative study of infectious complications of different types of chronic central venous access devices. Cancer 73(11):2832-2837 (Pubitemid 24166273)
29. Koolen DA, van Laarhoven HWM, Wobbes T, Punt CJA (2002) Single-centre experience with tunnelled central venous catheters in 150 cancer patients. Neth J Med 60(10):397-401 (Pubitemid 39089357)
30. Minassian VA, Sood AK, Lowe P, Sorosky JI, Al-Jurf AS, Buller RE (2000) Longterm central venous access in gynecologic cancer patients. J Am Coll Surg 191(4):403-409
31. Ng F, Mastoroudes H, Paul E, Davies N, Tibballs J, Hochhauser D et al (2007) A comparison of Hickman line- and Port-a-Cath-associated complications in patients with solid tumours undergoing chemotherapy. Clin Oncol 19(7):551-556 (Pubitemid 47181179)
32. Pegues D, Axelrod P, McClarren C, Eisenberg BL, Hoffman JP, Ottery FD et al (1992) Comparison of infections in Hickman and implanted port catheters in adult solid tumor patients. J Surg Oncol 49(3):156-162
33. Pracchia LF, Dias LCS, Dorlhiac-Llacer PE, DdAF Chamone (2004) Comparison of catheter-related infection risk in two different long-term venous devices in adult hematology-oncology patients. Rev Hospital Clin 59(5):291-295
34. Silver DF, Hempling RE, Recio FO, Piver MS, Eltabbakh GH (1989) Complications related to indwelling caval catheters on a gynecologic oncology service. Gynecol Oncol 70(3):329-333
35. Wacker P, Bugmann P, Halperin DS, Babel JF, Le Coultre C, Wyss M(1992) Comparison of totally implanted and external catheters in paediatric oncology patients. Eur J Cancer 28A(4-5):841-844
36. Zganjer M, Cizmic A, Butkovic D, Matolic M, Karaman-Ilic M, Stepan J (2008) Central venous catheters for chemotherapy of solid tumors: our results in the last 5 years. Coll Antropol 32(3):767-770